A cell culture/biotech company making strides in enhancing organ preservation and cell culturing at both room temperature and through cryopreservation. The LIFOR® technology is the nanoparticle component of the solution, which carries the oxygen or any type of drug or nutrient that the developers wish to place into the nanoparticle.
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
Makefield Therapeutics has licensed Intellectual Property covering a novel platform technology from Albert Einstein College of Medicine of Yeshiva University for the generation of powders comprised of hydrogel/glassy matrix (hybrid) nanoparticles that in a first application are delivering controlled and sustained therapeutic levels of gaseous nitric oxide
MSI's technology for multi-step multi-analyte chemiluminescent assays combines microfluidics, nanotechnology, and optoelectronics designed for both Immunoassay and Nucleic Acid Hybridization based applications.
The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.
Meda Biotech is a clinical-stage biopharmaceutical company developing a new class of Hybrid- Nanoengineering™ platform enables the design, engineering and manufacturing of Hybrid water soluble drugs with unprecedented control over drug properties to maximize trafficking to disease sites, dramatically enhancing efficacy while minimizing toxicities.
MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical, drug metabolism, pharmacokinetic, formulation and immunoassay support services to pharmaceutical and biotech companies worldwide.
Micronit Microfluidics focuses on developing, prototyping and manufacturing lab-on-a-chip products. Micronit has extensive experience supplying microfluidic solutions to the life sciences industry. Capabilities include nanofluidic channels (depth down to 100 nm).
MMI is a leading company providing scientists with innovative and sophisticated instruments which introduced the use of solid state laser capture microdissection, making this core technology in many scientific fields more efficient and cost effective. The patented adhesive cap is reliable, clean and easy to use. The company's products range from laser microdissection systems and optical tweezers to single cell technologies.
The main focus of our company is the development of precision scientific measuring instrumentation and equipment for research groups at universities and for the pharmaceutical industry, in the field of electrophysiology. MCS products reduce the labor intensive measuring and analyzing processes through miniaturization and automation.
NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.